openPR Logo
Press release

Granulocyte-Colony Stimulating Factor Market with Top Most Industry Players as BioCad, Celltrion Inc., Dong-A Socio Group, Pfizer Inc., Intas Pharmaceuticals Ltd, Novartis AG, Stada Arzneimittel AG and others

11-16-2018 11:46 AM CET | Health & Medicine

Press release from: Allied Market Research

Granulocyte-Colony Stimulating Factor Market

Granulocyte-Colony Stimulating Factor Market

The factors that drive the growth of the Global Granulocyte-Colony Stimulating Factor Market are increasing prevalence of cancer, growing awareness regarding the availability of various methods of cancer treatment, and rise in governmental funding towards healthcare. However, high costs of treatment modalities and stringent government regulations for approval of any new treatment options hamper the market growth.

Granulocyte-colony stimulating factor (G-CSF) is glycoprotein that stimulates the bone marrow to produce stem cells and granulocytes & release it into the bloodstream. G-CSF is produced by different tissues and its pharmacological analogs include lenograstim and filgrastim. G-CSF also stimulates proliferation, survival, differentiation, and function of mature & neutrophil precursors. G-CSF has a wide range of applications in hematology & oncology; a recombinant form of G-CSF is used with certain cancer-affected patients to reduce mortality and accelerate recovery from neutropenia after chemotherapy, thereby making way for higher-intensity treatment regimens.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/3472?utm_source=sy-Openpr

The key players of the global granulocyte-colony stimulating factor market include
• BioCad
• Celltrion Inc.
• Dong-A Socio Group
• Pfizer Inc.
• Intas Pharmaceuticals Ltd
• Novartis AG
• Stada Arzneimittel AG
• Teva Pharmaceutical Industries Ltd.
• Amgen Inc.
• Dr. Reddy's Laboratories.

The Global Granulocyte-Colony Stimulating Factor Market is segmented on the basis of type and application. Based on type, the market is categorised into capsule, tablet, and others. In terms of application, the market is divided into oncological diseases, blood disorders, growth hormone deficiencies, chronic and autoimmune disorders, and others. Regionally, the market has been analysed across North America, Europe, Asia-Pacific, and LAMEA.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/3472?utm_source=sy-Openpr

Key Benefits
• The study provides an in-depth analysis of the global granulocyte-colony stimulating factor market along with the current trends and future estimations to elucidate imminent investment pockets.
• Comprehensive analysis of the factors that drive and restrict the market growth has been provided in the report.
• Comprehensive quantitative analysis of the industry has been provided from 20162023 to assist stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps understand the trends in the types of granulocyte-colony stimulating factors globally.
• Key market players and their strategies have been provided to understand the competitive outlook of the industry.

Access Full Summery @ https://www.alliedmarketresearch.com/granulocyte-colony-stimulating-factor-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Granulocyte-Colony Stimulating Factor Market with Top Most Industry Players as BioCad, Celltrion Inc., Dong-A Socio Group, Pfizer Inc., Intas Pharmaceuticals Ltd, Novartis AG, Stada Arzneimittel AG and others here

News-ID: 1376855 • Views:

More Releases from Allied Market Research

Clean Hydrogen Market to Witness Comprehensive Growth by 2032
Clean Hydrogen Market to Witness Comprehensive Growth by 2032
Clean hydrogen is the form of hydrogen that is produced through processes that result in lower carbon emissions (through carbon capture, storage, and utilization (CCUS)) or zero carbon emissions. Climate change and net-zero commitments are major reasons for the shift from fossil fuels to alternatives such as synthetic fuels, renewables, nuclear fusion energy, clean hydrogen, and others. Several advanced hydrogen technologies are being developed and countries are positioning themselves to
Crash Barrier Systems Market 2021 to 2030: Growth Statistics, Facts and Regional Trends Hits a CAGR of 4.2%
Crash Barrier Systems Market 2021 to 2030: Growth Statistics, Facts and Regional …
According to a new report published by Allied Market Research, titled, , the global Crash Barrier Systems industry generated $7.8 billion in 2020, and is anticipated to generate $11.7 billion by 2030, witnessing a CAGR of 4.2% from 2021 to 2030. Prime determinants of growth Expansion of infrastructure, increase in road safety awareness, and growth in the automotive industry drive the growth of the global crash barrier systems market. However, high severity
Membrane Pump Market to Witness Exponential Growth by 2031
Membrane Pump Market to Witness Exponential Growth by 2031
A fossil fuel is a hydrocarbon-containing substance that is naturally produced in the Earth's crust from the remnants of deceased vegetation and creatures. Examples of fossil fuels include coal, gasoline, and natural gas. Fossil fuels can be consumed to produce energy, power motors (like internal combustion engines in cars), or provide heat for immediate use (like for cooking or heating). The fossil fuel energy market size was valued at $6.3
Non-Alcoholic Steatohepatitis (NASH) Market Strategic Imperatives for Success and Rising Demand Till 2025
Non-Alcoholic Steatohepatitis (NASH) Market Strategic Imperatives for Success an …
The global market for Non-Alcoholic Steatohepatitis (NASH) is on a rapid growth trajectory, driven by a surge in prevalence and advancements in therapeutic options. According to recent market analysis, the NASH market was valued at $1,179 million in 2017 and is projected to reach an impressive $21,478 million by 2025, representing a remarkable Compound Annual Growth Rate (CAGR) of 58.4% from 2021 to 2025. NASH, often referred to as a "silent

All 5 Releases


More Releases for Stimulating

4 Pivotal Trends Stimulating the Growth of Lactoferrin Market
Growing health consciousness among people and increasing proclivity towards healthy dietary lifestyle has tremendously increased the demand for efficient nutritional products. This has apparently evoked the adoption of lactoferrin supplements, foods and pharmaceutical products. The growing adoption can aptly be attributed to the benefits of lactoferrin such as iron absorption ability as well as anti-inflammatory, antibacterial, antioxidant and immunity boosting abilities in line with the novel product innovations by various
Follicle Stimulating Hormone Market Global In-depth Analysis 2019
Global Follicle Stimulating Hormone Market reports are thorough analysis a careful investigation of around the world which enables the client to assess the long haul based request and predicts exact executions. The development rate which is really anticipated relying upon the scholarly examination gives thorough data on the overall Follicle Stimulating Hormone industry. Access Full Information @ http://researchreport.biz/global-follicle-stimulating-hormone-market/ The drivers and restrictions are really assembled after the entire consciousness of the
Vast Applications in Bakery Industry Stimulating Revenue Growth
Global Bakery Enzymes Market Scenario Future Market Insights delivers key insights and presents a revised forecast of the global bakery enzymes market for a 10-year period from 2018 to 2028 for the report titled 'Bakery Enzymes Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028'. Revisions in the bakery enzymes market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving
Airway Management Devices Market Stimulating Players by 2025
Global Airway Management Devices Market: Overview The global airway management devices are medical devices used for patients have obstructed airways or are at the risk of being obstructed. These devices find applications in a variety of clinical settings such as emergency and pre-hospital settings, operating rooms, and out-of-hospital care. Over the past few years, they have gained wide application in managing supraglottic airways and in endotracheal intubation. The proper use
Erythropoietin Stimulating Agent Market : Analysis and Forecast by 2023
Blood carries oxygen which is required for a healthy body functioning. When the concentration of oxygen is reduced in the blood then an oxygen-sensing protein present in the kidney identifies the deficiency of oxygen gradient in the blood and then induces the EPO production,which then turns upon the erythroid cell line in the bone marrow to stimulate hematopoiesis and thus it response to the change in blood oxygen gradient. Endogenous
Follicle Stimulating Hormone Market
"This report studies the follicle stimulating hormone market. Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles. In this report, it refers to follicle stimulating hormone drugs for human use. 1 dose is equal to 75 IU." Scope of the Report: This report focuses on the Follicle Stimulating Hormone in United States market,